These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists. Turski L; Bressler K; Rettig KJ; Löschmann PA; Wachtel H Nature; 1991 Jan; 349(6308):414-8. PubMed ID: 1846943 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the time courses of selective gene expression and dopaminergic depletion induced by MPP+ in MN9D cells. Wang J; Duhart HM; Xu Z; Patterson TA; Newport GD; Ali SF Neurochem Int; 2008 May; 52(6):1037-43. PubMed ID: 18069091 [TBL] [Abstract][Full Text] [Related]
5. Blockade of 1-methyl-4-phenylpyridinium ion (MPP+) nigral toxicity in the rat by prior decortication or MK-801 treatment: a stereological estimate of neuronal loss. Srivastava R; Brouillet E; Beal MF; Storey E; Hyman BT Neurobiol Aging; 1993; 14(4):295-301. PubMed ID: 8103573 [TBL] [Abstract][Full Text] [Related]
6. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo. Saporito MS; Brown EM; Miller MS; Carswell S J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541 [TBL] [Abstract][Full Text] [Related]
7. A cell-permeable peptide inhibitor TAT-JBD reduces the MPP+-induced caspase-9 activation but does not prevent the dopaminergic degeneration in substantia nigra of rats. Pain S; Barrier L; Deguil J; Milin S; Piriou A; Fauconneau B; Page G Toxicology; 2008 Jan; 243(1-2):124-37. PubMed ID: 18037221 [TBL] [Abstract][Full Text] [Related]
8. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Novikova L; Garris BL; Garris DR; Lau YS Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572 [TBL] [Abstract][Full Text] [Related]
9. Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: implications for neurodegenerative diseases. Schulz JB; Matthews RT; Henshaw DR; Beal MF Neuroscience; 1996 Apr; 71(4):1043-8. PubMed ID: 8684608 [TBL] [Abstract][Full Text] [Related]
10. Biphasic mechanism of the toxicity induced by 1-methyl-4-phenylpyridinium ion (MPP+) as revealed by dynamic changes in glucose metabolism in rat brain slices. Maruoka N; Murata T; Omata N; Takashima Y; Fujibayashi Y; Wada Y Neurotoxicology; 2007 May; 28(3):672-8. PubMed ID: 17391768 [TBL] [Abstract][Full Text] [Related]
12. Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia. Yang Y; Li Q; Shuaib A Exp Neurol; 2000 May; 163(1):39-45. PubMed ID: 10785442 [TBL] [Abstract][Full Text] [Related]
13. Dopamine transporter function assessed by antisense knockdown in the rat: protection from dopamine neurotoxicity. Van Kampen JM; McGeer EG; Stoessl AJ Synapse; 2000 Sep; 37(3):171-8. PubMed ID: 10881039 [TBL] [Abstract][Full Text] [Related]
14. MPP(+) increases the vulnerability to oxidative stress rather than directly mediating oxidative damage in human neuroblastoma cells. Lee HS; Park CW; Kim YS Exp Neurol; 2000 Sep; 165(1):164-71. PubMed ID: 10964495 [TBL] [Abstract][Full Text] [Related]
15. Inhibitors of mitochondrial respiration, iron (II), and hydroxyl radical evoke release and extracellular hydrolysis of glutathione in rat striatum and substantia nigra: potential implications to Parkinson's disease. Han J; Cheng FC; Yang Z; Dryhurst G J Neurochem; 1999 Oct; 73(4):1683-95. PubMed ID: 10501216 [TBL] [Abstract][Full Text] [Related]
16. Effects of alpha-phenyl-N-tert-butyl nitrone and N-acetylcysteine on hydroxyl radical formation and dopamine depletion in the rat striatum produced by d-amphetamine. Wan FJ; Tung CS; Shiah IS; Lin HC Eur Neuropsychopharmacol; 2006 Feb; 16(2):147-53. PubMed ID: 16061357 [TBL] [Abstract][Full Text] [Related]
17. Intrastriatal infusion of the Parkinsonian neurotoxin, MPP(+), induces damage of striatal cell nuclei in Sprague-Dawley rats. Banerjee R; Sreetama S; Saravanan KS; Chandra G; Nath De S; Mohanakumar KP J Chem Neuroanat; 2006 Dec; 32(2-4):90-100. PubMed ID: 16822645 [TBL] [Abstract][Full Text] [Related]
18. Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum. Theodore S; Cass WA; Maragos WF Neuroscience; 2006 Feb; 137(3):925-35. PubMed ID: 16338084 [TBL] [Abstract][Full Text] [Related]
19. Comparison of neuroprotective effects induced by alpha-phenyl-N-tert-butyl nitrone (PBN) and N-tert-butyl-alpha-(2 sulfophenyl) nitrone (S-PBN) in lithium-pilocarpine status epilepticus. Peterson SL; Purvis RS; Griffith JW Neurotoxicology; 2005 Dec; 26(6):969-79. PubMed ID: 15890407 [TBL] [Abstract][Full Text] [Related]